Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Pharmacol. 2001 Jun;1(3):248-53.

Eotaxin and asthma.

Author information

  • 1Division of Biomedical Sciences, Imperial College School of Medicine, London, UK. j.pease@ic.ac.uk

Abstract

Eotaxin is a small protein that is produced in the lungs of asthmatic patients and is a potent chemoattractant for eosinophils. Eotaxin, a CC chemokine, stimulates the migration of eosinophils from the small blood vessels in the lungs by acting on the CC chemokine receptor CCR3, which is located on the leukocyte cell surface. In the past year, three low molecular weight compounds have been developed that can block this receptor. Such compounds may be developed into orally available drugs aimed at preventing eosinophil recruitment and, hence, the pathogenesis associated with the activation of these cells within the lung tissue.

PMID:
11712747
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center